![Nathalie Thomas-Pujol](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Nathalie Thomas-Pujol worked as Head of Regulatory Affairs at Cephalon, Inc. She then worked as Head of Regulatory Affairs at Neovacs SA from 2014 to 2018.
Prior to that, she was Head of Biochemistry at Université de Rouen Normandie.
Dr. Thomas-Pujol holds a doctorate degree from Université Paris Diderot-Paris 7 and another doctorate degree from Université de Rouen Normandie.
Former positions of Nathalie Thomas-Pujol
Companies | Position | End |
---|---|---|
NEOVACS | General Counsel | 2017-12-31 |
Université de Rouen Normandie | Corporate Officer/Principal | - |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | General Counsel | - |
Training of Nathalie Thomas-Pujol
Université de Rouen Normandie | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEOVACS | Health Technology |
Private companies | 2 |
---|---|
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Université Paris Diderot-Paris 7 | Consumer Services |
- Stock Market
- Insiders
- Nathalie Thomas-Pujol